These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1745690)
1. Antide (Nal-Lys GnRH antagonist) suppression of pituitary-testicular function and sexual behavior in group-living rhesus monkeys. Wallen K; Eisler JA; Tannenbaum PL; Nagell KM; Mann DR Physiol Behav; 1991 Aug; 50(2):429-35. PubMed ID: 1745690 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. II. Development of an in vitro bioassay for characterization of pharmacokinetics and pharmacodynamics of antide in circulation. Danforth DR; Williams RF; Gordon K; Leal JA; Hodgen GD Endocrinology; 1991 Apr; 128(4):2041-4. PubMed ID: 1900785 [TBL] [Abstract][Full Text] [Related]
3. Sexual maturation in male rhesus monkeys: importance of neonatal testosterone exposure and social rank. Mann DR; Akinbami MA; Gould KG; Paul K; Wallen K J Endocrinol; 1998 Mar; 156(3):493-501. PubMed ID: 9582506 [TBL] [Abstract][Full Text] [Related]
4. Effects of neonatal testicular suppression with a GnRH antagonist on social behavior in group-living juvenile rhesus monkeys. Wallen K; Maestripieri D; Mann DR Horm Behav; 1995 Sep; 29(3):322-37. PubMed ID: 7490008 [TBL] [Abstract][Full Text] [Related]
5. Extended presence of antide (Nal-Lys GnRH antagonist) in circulation: prolonged duration of gonadotropin inhibition may derive from antide binding to serum proteins. Danforth DR; Gordon K; Leal JA; Williams RF; Hodgen GD J Clin Endocrinol Metab; 1990 Feb; 70(2):554-6. PubMed ID: 2298867 [TBL] [Abstract][Full Text] [Related]
7. Probing studies on multiple dose effects of antide (Nal-Lys) GnRH antagonist in ovariectomized monkeys. Leal JA; Gordon K; Williams RF; Danforth DR; Roh SI; Hodgen GD Contraception; 1989 Nov; 40(5):623-33. PubMed ID: 2515029 [TBL] [Abstract][Full Text] [Related]
8. Blockade of neonatal activation of the pituitary-testicular axis with continuous administration of a gonadotropin-releasing hormone agonist in male rhesus monkeys. Mann DR; Davis-DaSilva M; Wallen K; Coan P; Evans DE; Collins DC J Clin Endocrinol Metab; 1984 Aug; 59(2):207-11. PubMed ID: 6376528 [TBL] [Abstract][Full Text] [Related]
9. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. I. In vitro studies on mechanism of action. Danforth DR; Williams RF; Gordon K; Hodgen GD Endocrinology; 1991 Apr; 128(4):2036-40. PubMed ID: 1900784 [TBL] [Abstract][Full Text] [Related]
11. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B". Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis). Weinbauer GF; Nieschlag E Andrologia; 1993; 25(3):141-7. PubMed ID: 8517553 [TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of a gonadotrophin-releasing hormone antagonist on pituitary and testicular function in monkeys. Bint Akhtar F; Weinbauer GF; Nieschlag E J Endocrinol; 1985 Mar; 104(3):345-54. PubMed ID: 3882872 [TBL] [Abstract][Full Text] [Related]
14. Influence of continuous gonadotropin-releasing hormone (GnRH) agonist treatment on luteinizing hormone and testosterone secretion, the response to GnRH, and the testicular response to human chorionic gonadotropin in male rhesus monkeys. Mann DR; Gould KG; Collins DC J Clin Endocrinol Metab; 1984 Feb; 58(2):262-7. PubMed ID: 6363435 [TBL] [Abstract][Full Text] [Related]
15. Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys. Duffy DM; Stewart DR; Stouffer RL J Clin Endocrinol Metab; 1999 Jan; 84(1):342-9. PubMed ID: 9920105 [TBL] [Abstract][Full Text] [Related]
16. Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis). Weinbauer GF; Surmann FJ; Akhtar FB; Shah GV; Vickery BH; Nieschlag E Fertil Steril; 1984 Dec; 42(6):906-14. PubMed ID: 6389185 [TBL] [Abstract][Full Text] [Related]
17. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334 [TBL] [Abstract][Full Text] [Related]
18. Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). Weinbauer GF; Behre HM; Fingscheidt U; Nieschlag E Endocrinology; 1991 Oct; 129(4):1831-9. PubMed ID: 1915071 [TBL] [Abstract][Full Text] [Related]
19. Blockade of neonatal activation of the pituitary-testicular axis: effect on peripubertal luteinizing hormone and testosterone secretion and on testicular development in male monkeys. Mann DR; Gould KG; Collins DC; Wallen K J Clin Endocrinol Metab; 1989 Mar; 68(3):600-7. PubMed ID: 2493038 [TBL] [Abstract][Full Text] [Related]
20. Single dose long-term suppression of testosterone secretion by a gonadotropin-releasing hormone antagonist (Antide) in male monkeys. Edelstein MC; Gordon K; Williams RF; Danforth DR; Hodgen GD Contraception; 1990 Aug; 42(2):209-14. PubMed ID: 2085971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]